Large scale ex vivo expansion of clinical-grade effector cells for adoptive immunotherapy.

about

Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against infection

P2860

Q57497157-D5B56DAA-696A-4029-9CDE-9ECAE5B93F96

P2860

Large scale ex vivo expansion of clinical-grade effector cells for adoptive immunotherapy.

Item

http://www.wikidata.org/entity/Q47099286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@en

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@nl

type

Item

label

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@en

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@nl

prefLabel

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@en

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@nl

P1476

Large scale ex vivo expansion ...... ls for adoptive immunotherapy.

@en

P2093

Changling Li

http://www.w3.org/2001/XMLSchema#string

Di Lin

http://www.w3.org/2001/XMLSchema#string

Dongchu Ma

http://www.w3.org/2001/XMLSchema#string

Huiying Yu

http://www.w3.org/2001/XMLSchema#string

Jingang Yang

http://www.w3.org/2001/XMLSchema#string

Junde Liu

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Yinghui Sun

http://www.w3.org/2001/XMLSchema#string

Zien Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?

Trastuzumab--mechanism of action and use in clinical practice

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

The biology of interleukin-2.

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.

P304

5678-5686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285110

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5740814

http://www.w3.org/2001/XMLSchema#string

Large scale ex vivo expansion of clinical-grade effector cells for adoptive immunotherapy.

about

P2860

P2860

Large scale ex vivo expansion of clinical-grade effector cells for adoptive immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932